Note that 117 NB patients without MYCN gene amplification in this dataset were divided into low‐risk group (patient without disease relapse) and high‐risk group (patient with disease relapse, including metastases) in the minimum of 5 years from diagnosis. The gene discussed is MYCN; the disease is neuroblastoma.